Author(s): Fischer GW, Levin MA
Abstract Share this page
Abstract Vasoplegic syndrome (VS) is a recognized and relatively common complication of cardiopulmonary bypass (CPB), appearing with an incidence ranging between 5\% and 25\%. It is characterized by significant hypotension, high or normal cardiac outputs and low systemic vascular resistance (SVR), and increased requirements for fluids and vasopressors during or after CPB. Patients developing VS are at increased risk for death and other major complications following cardiac surgery. This review will focus on the pathophysiology and contemporary strategies of treating VS encountered after CPB. Copyright © 2010 Elsevier Inc. All rights reserved.
This article was published in Semin Thorac Cardiovasc Surg
and referenced in Journal of Anesthesia & Clinical Research